THE Food and Drug Administration (FDA) ADMITS IT HAS NEVER LICENSED ANY INFLUENZA VACCINE FOR USE BY PREGNANT WOMEN AND DOES NOT HAVE A SINGLE CLINICAL TRIAL SUPPORTING THE SAFETY OF THIS PRACTICE.
ICAN submitted a Freedom of Information Act (FOIA) request to the Food and Drug Administration (FDA), requesting copies of the clinical trials it relied upon when licensing any influenza vaccine for use in pregnant women. When the FDA failed to respond to this request an appeal, and lawsuit, ensued. In the end, as seen from the document which ended the lawsuit, it is clear the FDA has not licensed any influenza vaccine as an indicated use for pregnant women, let alone conducted or required any pharmaceutical company to conduct any clinical trial which supports the safety of injecting pregnant women with the influenza vaccine.
THE ICAN NOTICE TO FDA REGARDING AN APPARENT ERROR IN THE PACKAGE INSERT FOR GARDASIL – Nov 2017
This notice was sent to the FDA in response to an apparent error misstating the number of systemic autoimmune events during the clinical trials of Gardasil-9.